Canlyniadau Chwilio - Jordan, Justin

Unrecognized cobalamin deficiency, nitrous oxide, and reversible subacute combined degeneration gan Jordan, Justin T., Weiser, Julia, Van Ness, Paul C.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

PALL-08. HOSPICE USE AMONG PATIENTS WITH HIGH GRADE GLIOMAS gan Forst, Deborah, Adams, Eric, Nipp, Ryan, Martin, Allison, Aizer, Ayal, Jordan, Justin

Cael y testun llawn Cael y testun llawn

Education Research: Neurology resident education: Trending skills, confidence, and professional preparation gan Jordan, Justin T., Mayans, David, Schneider, Logan, Adams, Nellie, Khawaja, Ayaz M., Engstrom, John

Cael y testun llawn Cael y testun llawn Cael y testun llawn

ACTR-36. A SINGLE ARM PHASE 2 STUDY OF THE DUAL mTORC1/mTORC2 INHIBITOR VISTUSERTIB PROVIDED ON AN INTERMITTENT SCHEDULE FOR NEUROFIBROMATOSIS 2 PATIENTS WITH PROGRESSIVE OR SYMPTO... gan Plotkin, Scott, Jordan, Justin, Beauchamp, Roberta, Muzikansky, Alona, Stemmer-Rachamimov, Anat, Ramesh, Vijaya

Cael y testun llawn Cael y testun llawn

INNV-20. UTILITY OF TELEHEALTH FOR SPECIALTY NEUROFIBROMATOSIS (NF) CARE gan Jordan, Justin, Seijo, Marlon, Merker, Vanessa, Bhadola, Shivkumar, Thalheimer, Raquel, Plotkin, Scott R

Cael y testun llawn Cael y testun llawn

NIMG-66. LONG-TERM FOLLOW-UP OF NEUROFIBROMATOSIS TYPE 1 PATIENTS USING WHOLE-BODY MRI DEMONSTRATES DYNAMIC CHANGES IN INTERNAL NEUROFIBROMA SIZE gan Ly, Ina, Thalheimer, Raquel, Cai, Wenli, Bredella, Miriam, Merker, Vanessa, Plotkin, Scott, Jordan, Justin

Cael y testun llawn Cael y testun llawn

Hospice utilization in patients with malignant gliomas gan Forst, Deborah, Adams, Eric, Nipp, Ryan, Martin, Allison, El-Jawahri, Areej, Aizer, Ayal, Jordan, Justin T

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schw... gan Merker, Vanessa L., Dai, Annie, Radtke, Heather B., Knight, Pamela, Jordan, Justin T., Plotkin, Scott R.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Effective Provider-Patient Communication of a Rare Disease Diagnosis: A Qualitative Study of People Diagnosed with Schwannomatosis gan Merker, Vanessa L., Plotkin, Scott R., Charns, Martin P., Meterko, Mark, Jordan, Justin T., Elwy, A. Rani

Cael y testun llawn Cael y testun llawn Cael y testun llawn

mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition gan Beauchamp, Roberta L., Erdin, Serkan, Witt, Luke, Jordan, Justin T., Plotkin, Scott R., Gusella, James F., Ramesh, Vijaya

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists gan Merker, Vanessa L., Knight, Pamela, Radtke, Heather B., Yohay, Kaleb, Ullrich, Nicole J., Plotkin, Scott R., Jordan, Justin T.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations gan DeWitt, John C, Jordan, Justin T, Frosch, Matthew P, Samore, Wesley R, Iafrate, A John, Louis, David N, Lennerz, Jochen K

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Correlation between NF1 genotype and imaging phenotype on whole-body MRI: NF1 radiogenomics gan Liu, Yunpeng, Jordan, Justin T., Bredella, Miriam A., Erdin, Serkan, Walker, James A., Vangel, Mark, Harris, Gordon J., Plotkin, Scott R., Cai, Wenli

Cael y testun llawn Cael y testun llawn Cael y testun llawn

NIMG-07. LONG-TERM FOLLOW-UP OF SCHWANNOMA GROWTH BEHAVIOR IN ADULT NEUROFIBROMATOSIS TYPE 2 AND SCHWANNOMATOSIS PATIENTS USING WHOLE-BODY MRI gan Ly, Ina, Thalheimer, Raquel, Cai, Wenli, Bredella, Miriam, Muzikansky, Alona, Merker, Vanessa, Herr, Hamilton, Da, Jennifer, Harris, Gordon, Plotkin, Scott, Jordan, Justin

Cael y testun llawn Cael y testun llawn

The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research gan Radtke, Heather B., Klein-Tasman, Bonita P., Merker, Vanessa L., Knight, Pamela, Ullrich, Nicole J., Jordan, Justin T., Korf, Bruce, Plotkin, Scott R.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI gan Zhang, Jian-Wei, Chen, Wei, Ly, K. Ina, Zhang, Xubin, Yan, Fan, Jordan, Justin, Harris, Gordon, Plotkin, Scott, Hao, Pengyi, Cai, Wenli

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities gan Klesse, Laura J., Jordan, Justin T., Radtke, Heather B., Rosser, Tena, Schorry, Elizabeth, Ullrich, Nicole, Viskochil, David, Knight, Pamela, Plotkin, Scott R., Yohay, Kaleb

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Quality improvement in neurology: Neuro-Oncology Quality Measurement Set gan Jordan, Justin T, Sanders, Amy E, Armstrong, Terri, Asher, Tony, Bennett, Amy, Dunbar, Erin, Mohile, Nimish, Nghiemphu, P Leia, Smith, Timothy R, Ney, Douglas E

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Mind-Body Treatment for International English-Speaking Adults With Neurofibromatosis via Live Videoconferencing: Protocol for a Single-Blind Randomized Controlled Trial gan Vranceanu, Ana-Maria, Zale, Emily L, Funes, Christopher J, Macklin, Eric A, McCurley, Jessica, Park, Elyse R, Jordan, Justin T, Lin, Ann, Plotkin, Scott R

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Temozolomide therapy for aggressive functioning pituitary adenomas refractory to surgery and radiation: a case series gan Jordan, Justin T, Miller, Julie J, Cushing, Tucker, Seijo, Marlon, Batchelor, Tracy T, Arrillaga-Romany, Isabel C, Shih, Helen A, Nachtigall, Lisa B, Loeffler, Jay S, Dietrich, Jorg

Cael y testun llawn Cael y testun llawn Cael y testun llawn